Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight [Yahoo! Finance]
Certara, Inc. (CERT)
Company Research
Source: Yahoo! Finance
drug development (MIDD), the growing complexity of modern drug development, and the rising emphasis on personalized and precision medicine. MIDD strategies allow pharmaceutical companies to leverage advanced computational models to forecast drug behavior, refine dosing strategies, and minimize dependence on expensive clinical trials, ultimately speeding up development timelines. New York, USA, April 27, 2026 (GLOBE NEWSWIRE) Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight The biosimulation market is witnessing robust expansion, fueled by the increasing adoption of model-informed drug development (MIDD), the growing complexity of modern drug development, and the rising emphasis on personalized and precision medicine. MIDD strategies allow pharmaceutical companies to leverage advanced computational models to forecast drug behavior, refine dosing strategies, and minimize dependence on expensive clinical trials, ultimately speeding
Show less
Read more
Impact Snapshot
Event Time:
CERT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERT alerts
High impacting Certara, Inc. news events
Weekly update
A roundup of the hottest topics
CERT
News
- AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, Chemaxon - Global Forecast to 2030 and 2035 [Yahoo! Finance]Yahoo! Finance
- How The Certara (CERT) Story Is Shifting As Analysts Recut Targets And Expectations [Yahoo! Finance]Yahoo! Finance
- Certara: An Interesting Situation To Keep Track Off [Seeking Alpha]Seeking Alpha
- Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat [Yahoo! Finance]Yahoo! Finance
- Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to VeristatGlobeNewswire
CERT
Earnings
- 2/26/26 - Beat
CERT
Sec Filings
- 4/28/26 - Form D
- 4/22/26 - Form 8-K
- 4/6/26 - Form SCHEDULE
- CERT's page on the SEC website